Literature DB >> 8389986

Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium.

H R Zerkowski1, A Broede, K Kunde, S Hillemann, E Schäfer, M Vogelsang, M C Michel, O E Brodde.   

Abstract

The receptor systems through which serotonin (5-HT), histamine, angiotensin II and endothelin increase the force of contraction were studied in isolated right atria from patients without apparent heart failure. All agonists increased the atrial force of contraction in a concentration-dependent manner; maximal effects, however, were significantly less than those evoked by isoprenaline or Ca2+. 5-HT and histamine, but not angiotensin II and endothelin, activated adenylate cyclase, whereas endothelin and angiotensin II stimulated inositol phosphate generation. Experiments with subtype-selective antagonists revealed that histamine effects were mediated by H2-receptors (sensitive to ranitidine), 5-HT-effects by 5-HT4-receptors (sensitive to SDZ 205-557) and angiotensin II effects by AT1-receptors (sensitive to losartan). We conclude that in human right atria the force of contraction can be increased by cyclic AMP-dependent (histamine, 5-HT) and -independent (angiotensin II, endothelin) pathways. Compared to beta-adrenoceptors, however, all other receptor systems increase the force of contraction only submaximally indicating that the beta-adrenoceptor pathway is the most important physiological mechanism to regulate force of contraction and/or heart rate in the human heart.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389986     DOI: 10.1007/bf00165383

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

Review 1.  Nonpeptide angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

2.  SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum.

Authors:  K H Buchheit; R Gamse; H J Pfannkuche
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

3.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

4.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium.

Authors:  M Takanashi; M Endoh
Journal:  Am J Physiol       Date:  1991-09

7.  Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart.

Authors:  L Brown; N M Deighton; S Bals; W Söhlmann; H R Zerkowski; M C Michel; O E Brodde
Journal:  J Cardiovasc Pharmacol       Date:  1992-02       Impact factor: 3.105

8.  A 5-HT4-like receptor in human left atrium.

Authors:  L Sanders; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.

Authors:  H Ouadid; J Seguin; A Dumuis; J Bockaert; J Nargeot
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

10.  On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies.

Authors:  S Motomura; H Reinhard-Zerkowski; A Daul; O E Brodde
Journal:  Am Heart J       Date:  1990-03       Impact factor: 4.749

View more
  16 in total

Review 1.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186.

Authors:  S G Parker; E M Taylor; S A Hamburger; M Vimal; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways.

Authors:  M Meyer; S Lehnart; B Pieske; K Schlottauer; S Munk; C Holubarsch; H Just; G Hasenfuss
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

4.  Blockade of human atrial 5-HT4 receptors by GR 113808.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle.

Authors:  F S Tam; K Hillier; K T Bunce; C Grossman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells.

Authors:  R Leurs; M J Smit; W M Menge; H Timmerman
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

Review 7.  Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Authors:  Jens Kockskämper; Aleksey V Zima; H Llewelyn Roderick; Burkert Pieske; Lothar A Blatter; Martin D Bootman
Journal:  J Mol Cell Cardiol       Date:  2008-06-15       Impact factor: 5.000

8.  Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist.

Authors:  A J Kaumann; L M Gaster; F D King; A M Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

9.  Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Chronic beta 1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: rôle of cyclic nucleotides.

Authors:  L Sanders; J A Lynham; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.